Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tilrekimig in Severe Asthma
NCT07869043Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Sep 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 3 trial of tilrekimig in asthma, sponsored by Pfizer. Started Sep 2026; status: recruiting.
02
Drugs
tilrekimig
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07869043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869043.